by high-performance liquid chromatography (HPLC, Waters 600). All experiments were performed in accordance with the Ethical Committee for Animal Experiments (Northeast Agricultural University, Harbin, China).
Mating
Twelve Wistar rats were divided into 4 cages (one male and two females per cage) with an iron mesh on the bottom. On the next morning the vaginal suppository was observed under the iron mesh. When sperm was observed, the female rats were recorded as pregnant at day 0.
Determination of ketamine concentration via HPLC 2.3.1. Sample preparation
For the L group, cerebrospinal fluid was extracted from the foramen magnum 10 min after the intraperitoneal injection of ketamine; for the M and H groups, cerebrospinal fluid was collected immediately upon observing the loss of the righting reflex. First 0.5 mL of cerebrospinal fluid was added to 50 µL of sodium hydroxide (2 mol/L) and 5 mL of extraction solution (hexane : isopropanol : dichloromethane = 64:3:33) and mixed by vortexing for 30 s. Samples were repeatedly shaken for 20 min and the upper liquid part was absorbed. Samples were then blow-dried at 60 °C by nitrogen, dissolved in 1 mL of the mobile phase (methanol : phosphate = 13:7), vortexed for 30 s, and filtered with 0.22-µm microporous membranes (Millipore) for use.
Standard ketamine solution
A concentration gradient was obtained by diluting a standard ketamine solution (provided by the Department of Clinical Surgery of Veterinary Medicine, Northeast Agricultural University) to final concentrations of 10, 5, 2.5, 2, 1, and 0.5 µg/mL with ultrapure water, filtered through 0.22-µm microporous membranes for use.
Sample recovery rate
To analyze the recovery rate of ketamine, cerebrospinal fluid samples were divided into 3 parts, and equal volumes of ketamine standard solution at 1 µg/mL, 2 µg/mL, and 5 µg/mL were added.
Determination of precision
In order to evaluate the precision of our measurements, the injection of each concentration of standard solution was repeated four times a day, thus measuring peak height values and the coefficient of variation. The effect of different days was evaluated by injecting each concentration of standard solution 4 times in 4 days and measuring the peak height and the coefficient of variation.
Sample measurements
The column was a symmetrical C18 (4.6 mm × 150 mm, 5 µm, US Waters Company), the flow rate of the mobile phase (methanol : phosphate = 13:7) was 1.0 mL/min, the detection wavelength was 220 nm, the column temperature was 30 °C, and the injection volume was 20 µL. The utilized external standard cerebrospinal fluid concentration of ketamine was measured using the external standard.
Cell culture and identification of neural cells
Pregnant rats were euthanized at day 16-18 by cervical dislocation, and embryos were recovered to collect the hippocampus and cerebral cortex used for culturing neural cells (5) . The cells were cultured in BME (GIBCO) supplemented with 10% (v/v) fetal bovine serum (FBS) and penicillin/streptomycin (100 U/mL and 100 µg/mL) at 37 °C under an atmosphere of 5% CO 2 and 95% air. The verification of cultured cells was performed as follows. After removing the cell culture fluid, cells were fixed with 1 mL of paraformaldehyde/sugar mixture for 10 min and then placed in 1 mL of 0.1% (v/v) Triton X-100 for 10 min at room temperature. Cells were washed twice with PBS, then mixed with 10% FBS (Invitrogen, Cat. No. 16140071) for 1 h. Cells were then incubated with a mouse anti-MAP2 antibody (1:200, EnoGene Biotech) overnight at 4 °C, followed by goat antimouse IgG (1:100, Santa Cruz Biotechnology) for 1 h, and then washed three times with PBS. Green fluorescence was observed in the cytoplasm of cells positive for neuron-specific enolase by inverted microscope (Nikon Eclipse Ti-S). 2.5. GABA, DA, NE, 5-HT, and 5-HIAA measurements via LC-MS/MS 2.5.
Solution preparation
The ratio of standard dissolving liquid was water : acetonitrile : 0.1% formic acid = 50:25:25. The precision weights of GABA, DA, NE, 5-HT, and 5-HIAA with a standard of 0.0040 g were dissolved in standard dilutions of 40 mL, targeting a concentration of 100 µg/ mL standard stock solution, stored at 4 °C. The standard dilution preparation of cell culture medium was 10%. For formulated 5 mmol/L ammonium formate, mobile phase A was 5 mmol/L ammonium formate : acetonitrile = 95:5, and mobile phase B was 5 mmol/L ammonium formate : acetonitrile = 85:15.
Chromatographic conditions
The column was an XBridge BEH Amide XP Column (2.1 mm × 100 mm, 1.7 µm, US Waters Company). Column temperature was 30 °C, flow rate was 0.25 mL/min, and injection volume was 5 µL; an external standard was used. Mobile phase A was 5 mmol/L ammonium formate : acetonitrile = 95:5, and mobile phase B was 5 mmol/L ammonium formate : acetonitrile = 85:15; the gradient elution program is shown in Table 1 .
MS conditions
The ion source was ESI+ and the scan mode was multiple reaction monitoring. Capillary voltage was kept at 2.5 kV, while the source temperature was set at 15 °C and N 2 was used as the dissolving gas with a dissolving temperature of 450 °C. The dissolving gas flow rate was maintained at 650 L/h. The cone gas flow rate was kept at 50 L/h, Ar 2 was used as the collision gas, and the collision chamber working pressure was 3.3 × 10 -3 mbar. Ions and all other quantitative and qualitative parameters are listed in Table 2 .
Sample preparation
According to ketamine cerebrospinal fluid concentrations detected during anesthesia in the rats, four concentrations of ketamine for the nerve cells were determined. Ketamine was added on day 7 to the nerve cell culture, and 40 µL of supernatant was collected after dosing for 0, 5, 10, 15, 20, 25, 30, 45, 60, 90, and 120 min. Injection volumes of 5 µL and injection preparation vials were used and samples were filtered through a 0.22-µm filter membrane.
Linearity range and correlation coefficient
The precise amount of standard stock solution with standard dilution was diluted to concentration gradients of 1000, 500, 200, 100, 50, 20, and 10 ng/mL. Subsequent to filtering via 0.22-µm filter membranes, injections of 5 µL were administered.
Sensitivity measurement
According to the noise ratio (S/N), the values of the minimum detection limit and lower limit of quantification in the blank matrix were determined, five different levels of mixed standard solution were added, and different concentration gradients of the solution were formulated. Signals (peak height of the ratio of the count) and noise were measured when the lowest concentration of S/N > 3 reached the lowest concentration limit of detection at S/N > 10, and when recovery and relative standard deviations were in line with the requirements of the residue detection method they reached the minimum of the limit of quantitation.
Accuracy and precision
A blank sample was prepared with 100, 200, and 500 ng/mL concentrations of three quality control samples according to earlier detection and treatment methods. Five samples were prepared per concentration to determine the daily coefficients of variation. The time for each sample was checked until experimental UPLC-MS/MS methods for 5 min/day could be analyzed for all treated samples. Therefore, coefficients of variation were not measured that day and the methodological precision was evaluated according to the following formula: precision standard deviation (daily coefficients of variation) = standard deviation / average × 100%. Each concentration of five sample analyses used analyses of 5-µL injections to obtain the corresponding peak areas for each sample with the theoretical concentrations of added standard amount ratio calculations as the method of recovery.
Statistical analysis
All data were analyzed with GraphPad Prism 5.1 (GraphPad Software Inc., USA) by using one-way ANOVA followed by Turkey's post hoc test. Values were considered to be statistically significant at P < 0.05. Data are presented as mean ± standard deviation.
Results

Results of mating
Pessaries were checked under the iron mesh and smeared sperm was removed from the vagina and examined under a microscope. Day 0 was the day on which pregnancy was recorded. 
Linearity range and correlation coefficient
Linear regression was performed with standard ketamine concentration and peak area. Results showed a good linear relationship in the range of 0.5-10 µg/mL (Figure 1b) .
Sample recovery rate
The average recovery rate of ketamine was 96.17%, thus indicating that the used chromatographic conditions were reliable and the detection rate was high (Figure 1c ).
Determination of assay precision
Daily coefficients of variation of ketamine were 2.1%, 1.4%, 0.9%, and 1.6%, while daytime coefficients of variation were 2.1%, 2.3%, 1.2%, and 0.7%, respectively. The coefficient of variation was below 4%, indicating that the method was stable and reproducible.
Sample measurement
Rats were anesthetized using ketamine anesthesia. The blood concentration was measured, and we found that the concentrations of ketamine acting on nerve cells were 0.7, 1, 3, and 5 µg/mL (Table 3) .
Nerve cell culture and verification
Morphological changes of nerve cells were continuously observed under a microscope for 8 days. We observed the shape of embryonic neuronal cells that were round, small, bright, and scattered. Once seeded, after 3 h the cells adhered to the dish wall. After 4 days of culturing, the cells were significantly increased, with multiple protrusions growing out from the cell body. In this phase neurons showed their typical morphological characteristics, such as clear cell body, bright and raised, with adjacent cell processes that can form contacts (Figure 2a ). After 8 days of culturing, neuronal cell bodies increased, showing a distinct nucleus, and cell protrusions further increased and cells appeared to be moving closer to each other (Figure 2b) . Upon observation by laser confocal microscopy, cultured cortical neurons showed positivity for MAP2 (Figures 2c and 2d) , a marker in neurons from primitive cell cultures.
Establishment of LC-MS/MS detection method 3.4.1. Selection of MS conditions
The retention time of GABA, DA, NE, 5-HT, and 5-HIAA chromatographic peaks were as follows: 104.2, 154.1, 170.1, 177.2, and 192.1 m/z. The separation occurred in less than 2 min, and the peak shapes were good, as shown in Figures 3a-3e. 
Standard curve and linear range
The standard stock solutions were diluted to final concentrations of 1000, 500, 200, 100, 50, 20, and 10 ng/ mL in order to perform the LC-MS/MS analysis (Table 4) . 3.4.3. Determination of the detection limit and quantification limit To determine the detection limit and quantification limit of neurotransmitters in the analyzed samples we measured the lowest concentration of neurotransmitters when the S/N ratio was ≥3, revealing that the minimum detection limit was 6 ng/mL. On the other hand, the minimum quantitative limit when S/N was ≥10 was 20 ng/mL.
Results of GABA, DA, NE, 5-HT, and 5-HIAA recovery
Neurotransmitters at 100, 200, and 500 ng/mL were added to samples obtaining a good precision (CV less than 12%). The average recovery rate was 89.04%-97.29%. The accuracy and recovery rate of the tests are reported in Table 5 .
Detection of the five neurotransmitters
Effect of different concentrations of ketamine on GABA
In the rat group treated with 0.7 µg/mL of ketamine, the content of GABA had a significant increase (P < 0.01) at 60 and 90 min, respectively, compared with 0 min. In the rat group treated with 1 µg/mL of ketamine, GABA content significantly decreased (P < 0.01) at 10, 15, and 20 min, respectively, thereafter increasing. The rat group treated with 3 µg/mL of ketamine showed a decrease of GABA at 10, 15, 20, and 25 min, respectively, followed by an increase at 60 and 90 min (P < 0.05). Finally, when treated with 5 µg/mL of ketamine the content of GABA significantly (P < 0.01) decreased at 10, 15, and 20 min and then increased at 45, 60, and 90 min, respectively (Figures 4a and 4b) . 
Effect of different concentrations of ketamine on DA
In the rat group treated with 0.7 µg/mL of ketamine, the content of DA was significantly (P < 0.01) increased at 10, 15, and 20 min, respectively, compared with 0 min. In rats treated with 1 µg/mL of ketamine, the DA content was increased at 15 min but decreased at 60 min (P < 0.01). Rats treated with 3 µg/mL of ketamine showed an increase in DA at 10 min and 15 min, respectively. Finally, rats treated with 5 µg/mL of ketamine showed levels of DA significantly (P < 0.01) increased at 5 min, 10 min, 15 min, and 20 min, respectively (Figures 4c and 4d) .
Effect of different concentrations of ketamine on NE
Rats treated with 0.7 and 1 µg/mL of ketamine had significantly (P < 0.01) increased NE at 5, 10, 15, 20, and 25 min, respectively, compared with 0 min. In the rat group treated with 3 µg/mL of ketamine, the content of NE was significantly (P < 0.05) increased at 5, 10, 15, 20, and 25 min, respectively, but it decreased when rats were treated with 5 µg/mL of ketamine (P < 0.01) (Figures 4e and 4f) .
Effect of different concentrations of ketamine on 5-HT
We observed that different concentrations of ketamine induced 5-HT secretion by nerve cells according to different trends. Rats treated with 0.7 µg/mL of ketamine showed a significant (P < 0.01) decrease of 5-HT content at 15 min. In rats treated with 1 µg/mL of ketamine, 5-HT content was significantly (P < 0.05, P < 0.01) increased at 45 min and 60 min, respectively. Rats treated with 3 µg/ mL of ketamine had 5-HT content significantly (P < 0.01) decreased at 10 min; at 60 and 90 min, 5-HT content was increased (P < 0.01), respectively. Finally, in the group treated with 5 µg/mL of ketamine, 5-HT content was first significantly (P < 0.05, P < 0.01) decreased at 10 and 15 min, respectively, and then it significantly (P < 0.05, P < 0.01) increased at 90 and 120 min, respectively (Figures  4g and 4h) .
Effect of different concentrations ketamine on 5-HIAA
Rats treated with 0.7 µg/mL of ketamine showed an insignificant (P > 0.05) trend of 5-HIAA secretion by nerve cells. In the 1 µg/mL ketamine-treated group, 5-HIAA content was significantly increased at 60 min. In rats treated with 3 µg/mL of ketamine, 5-HIAA content at 45 min significantly (P < 0.01) increased with respect to the control group. Finally, in rats treated with 5 µg/mL of ketamine, 5-HIAA content at 10 min was significantly (P < 0.01) decreased. However, 5-HIAA content was significantly increased (P < 0.01) at 45, 60, and 90 min respectively (Figures 4i and 4j ).
Discussion
In this study, we observed that GABA, 5-HT, and 5-HIAA showed typical behaviors of neurotransmitters, with an initial increase followed by a decrease. These molecules reached their lowest point at 10-15 min and increased at 45-90 min, with a final declining trend. However, the contents of DA and NE behaved in an opposite manner. The changes observed in neurotransmitters showed a dose-dependent manner: with the increase of ketamine concentration, this tendency was clearer. This is consistent with the clinical phenomenon in vivo (6-8).
The common HPLC method classically used to measure neurotransmitters was not sensitive enough in this case, due to their low concentrations in the culture medium. Therefore, monoamine neurotransmitters (DA, NE, 5-HT, 5-HIAA) and GABA were detected by high-sensitivity liquid chromatography coupled with mass spectrometry (LC-MS/MS). The medium composition was complex, so we needed to dilute the analyzed samples 10-fold with ultrapure water in order to obtain better chromatographic results, and the retention time of each substance was less than 2 min.
The blood-cerebrospinal fluid barrier consists of tight junctions among epithelial cells of the choroid plexus structure, and it is responsible for transport of substances between the blood and cerebrospinal fluid (9) . The choroid plexus, involved in drainage back cerebrospinal fluid, presents solute carrier (SLC) transporter protein, able to regulate the transport of a variety of drugs available through the blood and cerebrospinal fluid that are essential for nerve cells to survive (10) . Moreover, it can better reflect the brain's extracellular fluid level through the blood-brain barrier. As a consequence, the blood concentration of ketamine used as an anesthetic can be detected by analyzing nerve cells. In the range of 1-5 µg/ mL of ketamine, we chose the following concentrations: 1, 3, and 5 µg/mL, along with the low-dose group with 0.7 µg/ mL of ketamine. Cells derived from rats belonging to the high-dose groups were rapidly broken as we observed by microscopy. We thus chose the above four concentrations of ketamine.
Many anesthetics have a certain effect on ion channels, neurotransmitter receptors, and extracellular ion concentrations. Previous experiments indicated (11) that volatile anesthetics inhibit the central nervous system through the inhibition of postsynaptic and presynaptic receptors. In the nervous system, ketamine strengthens the role of GABA (12, 13) , which is an important amino acid neurotransmitter (14, 15) . It has the function of excitatory and inhibitory effect on the activity and mutual relations of neurons.
At present, the relationship between ketamine and the GABA A receptor is still controversial. Some studies have shown that ketamine can enhance the inhibitory postsynaptic currents mediated by GABA at clinically relevant concentrations. Ketamine can stimulate GABAinduced chloride currents in Xenopus oocytes, thus suggesting that it may have a role in GABA A receptorinvolved processes (16) . L-Amino acid dehydrogenase had no effect on the generation of ketamine anesthesia, presynaptic GABA A neurotransmission did not require higher levels of ketamine, or it may not have an effect by indirect efficacy in the neural network (17) . The use of ketamine in Xenopus oocytes further showed the relationship between ketamine and GABA.
In the central nervous system, the content of DA is mainly determined by the synthesis rate of dopaminergic neurons. When the action potential is triggered, DA is released into the synaptic cleft to begin the process of transmission. In vitro experiments showed that a subanesthetic dose of ketamine can stimulate highaffinity D2 receptors. However, under anesthesia doses, it can block the high-affinity D2 dopamine receptors. In addition, Kapur and Seeman (18) reported that ketamine has a strong affinity for the dopamine D2 receptor, which indicates that ketamine can also regulate the dopamine system. Several studies have demonstrated that subanesthetic doses of ketamine can allow the rapid release of DA to the rat forebrain cortex. When the test was repeated, higher basal levels of DA were detected, thus indicating that repeated application of ketamine may have more lasting impact (19) . Ketamine at 2 mM (internal embryo exposure levels equivalent to human anesthetic plasma concentration) significantly reduced DA levels, indicating that DA synthesis was adversely affected (20) . In long-term ketamine-treated mice, significant increases of DA contents were found in the midbrain (21) . This experiment showed that DA increased from 45 to 120 min, but the difference was not significant. This may be the result of short-term effects of ketamine.
In the central nervous system, NE is has many physiological functions, including roles in the sleep/ wake cycle, pressure perception, the cardiovascular system cycle, perception, and learning, but it is also an important indicator of general anesthesia. Locus coeruleus activity can affect the MAC of the anesthetic, and locus coeruleus neurons are stimulated during recovery from anesthesia (22) . Reports showed that the release of NE in the hypothalamus is increased in halothane and isoflurane anesthesia recovery processes (23) . Ketamine can partially inhibit NE reuptake so that circulating levels of catecholamine increase, inhibiting the central nervous system from reabsorbing it.
5-HT is also called serotonin, an indole-alkylamine complex synthesized by the brain. It is involved in nerve development and other processes. 5-HIAA is an important bioactive molecule, present in body fluids such as cerebrospinal fluid and also in platelets. Under the action of monoamine oxidase, 5-HT is degraded into 5-HIAA, so the content of 5-HIAA indirectly reflects the consumption of 5-HT in the body.
As typical inhibitory neurotransmitters, the trends observed in levels of 5-HT and 5-HIAA were in line with the trend of GABA, but in contrast with the trends of DA and NE. In vitro experiments have shown that ketamine is a 5-HT receptor agonist, which may inhibit complex G protein-coupled receptors, such as adrenaline and muscarinic and opioid receptors (1, 24) . Some studies (25, 26) used ketamine to anesthetize rats and to detect DA, NE, 5-HT, and 5-HIAA in brain, finding that when rats were deeply anesthetized, the 5-HT content was increased but 5-HIAA showed an opposite trend. The contents of NE and DA were significantly increased during ketamine anesthesia and the recovery process. However, the decrease of 5-HIAA may be associated with the deepening of ketamine anesthesia (10) . In our work, the content of 5-HIAA was significantly increased upon ketamine treatment, which may be due to the exclusion of the effects related to complex mechanisms in vitro. Moreover, its trend is broadly in line with that of 5-HT, maybe because 5-HT is a precursor of 5-HIAA, and it did not significantly affect the degradation process. However, this aspect needs to be further investigated.
In conclusion, the direct effect of ketamine anesthetic concentration in nerve cells results in a significant impact on monoamine neurotransmitters and GABA. Accordingly, with clinical changes in anesthetized rats, the role of ketamine in anesthesia may be explained by the changes induced in these neurotransmitters. Thus, ketamine may act by inhibiting the production and storage of excitatory neurotransmitters, and by promoting the generation and storage of inhibitory neurotransmitters. The anesthetic action may be thus related to a reduction of messenger molecules' relative content and related enzyme activity.
